Filing Details

Accession Number:
0001385508-18-000043
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-15 18:44:15
Reporting Period:
2018-05-11
Accepted Time:
2018-05-15 18:44:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385508 Opiant Pharmaceuticals Inc. OPNT Metal Mining (1000) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1689819 T. Thomas Thomas C/O Opiant Pharmaceuticals, Inc.
201 Santa Monica Blvd
Santa Monica CA 90401
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-11 7,063 $10.00 7,063 No 4 M Direct
Common Stock Disposition 2018-05-14 3,500 $18.54 3,563 No 4 S Direct
Common Stock Disposition 2018-05-15 800 $17.53 2,763 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-05-11 15,000 $0.00 7,063 $10.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,334 2017-08-29 2021-11-03 No 4 M Direct
Footnotes
  1. Reflects the net cashless exercise of an option to purchase 15,000 shares, which resulted in the issuance of a net 7,063 shares to the optionee, and an effective reduction of 7,937 shares based on the following formula. Number of shares = number of options times (current stock price of $18.90 less exercise price of $10) divided by the current stock price of $18.90 to fund the cashless exercise of 7,063 options